Colgate-Palmolive Company(CL)Earnings, Financials & Key Ratios

CL•NYSE

$86.33

$69.26B mkt cap·32.8× P/E·Price updated May 6, 2026

SectorConsumer Defensive IndustryHousehold Products Sub-IndustryPersonal Care and Beauty Products

AboutColgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.Show more

Revenue$20.38B+1.4%
EBITDA$4.98B-0.2%
Net Income$2.13B-26.2%
EPS (Diluted)2.63-25.1%
Gross Margin60.11%-0.2%
EBITDA Margin24.42%-1.6%
Operating Margin21.33%-2.2%
Net Margin10.46%-27.2%
ROE469.09%+21.9%
ROIC43.41%+12.3%
Debt/Equity21.88+39.9%
Interest Coverage12.46-14.4%

Analysis→Technical→

CL Key Insights

Colgate-Palmolive Company (CL) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Excellent 3Y average ROE of 371.6%
✓FCF machine: 17.8% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 2.6%
✓Healthy 5Y average net margin of 11.8%
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

✗High debt to equity ratio of 21.9x
✗Expensive at 191.8x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

CL Price & Volume

Colgate-Palmolive Company (CL) stock price & volume — 10-year historical chart

Loading chart...

CL Growth Metrics

Colgate-Palmolive Company (CL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years2.43%

5 Years4.35%

3 Years4.29%

TTM1.4%

Profit CAGR

10 Years4.42%

5 Years-4.58%

3 Years6.1%

TTM-26.26%

EPS CAGR

10 Years5.64%

5 Years-3.48%

3 Years7.28%

TTM-25.45%

Return on Capital

10 Years38.86%

5 Years36.61%

3 Years38.98%

Last Year41.65%

CL Recent Earnings

Colgate-Palmolive Company (CL) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 12/12 qtrs (100%)●Beat Revenue 11/12 qtrs (92%)

Q2 2026Latest

May 1, 2026

EPS

$0.97

Est $0.94

+2.9%

Revenue

$5.3B

Est $5.2B

+2.1%

Q1 2026

Jan 30, 2026

EPS

$0.95

Est $0.91

+4.2%

Revenue

$5.2B

Est $5.1B

+2.1%

Q4 2025

Oct 31, 2025

EPS

$0.91

Est $0.89

+2.4%

Revenue

$5.1B

Est $5.1B

+0.1%

Q3 2025

Aug 1, 2025

EPS

$0.92

Est $0.90

+2.6%

Revenue

$5.1B

Est $5.0B

+1.5%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 1, 2026	$0.97vs $0.94+2.9%	$5.3Bvs $5.2B+2.1%
Q1 2026	Jan 30, 2026	$0.95vs $0.91+4.2%	$5.2Bvs $5.1B+2.1%
Q4 2025	Oct 31, 2025	$0.91vs $0.89+2.4%	$5.1Bvs $5.1B+0.1%
Q3 2025	Aug 1, 2025	$0.92vs $0.90+2.6%	$5.1Bvs $5.0B+1.5%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
PGThe Procter & Gamble CompanyDirect Competitor	338.64B	144.92	22.26	0.29%	14.66%	23.78%	4.15%	0.68
ULUnilever PLCDirect Competitor	127.64B	58.42	21.74	1.94%	10.16%	61.19%	7.15%	1.36
KMBKimberly-Clark CorporationDirect Competitor	32.26B	97.20	16.01	-14.17%	12.81%	131.68%	5.08%	4.34
CHDChurch & Dwight Co., Inc.Direct Competitor	22.15B	93.53	30.97	1.57%	11.81%	17.45%	4.93%	0.55
ENREnergizer Holdings, Inc.Direct Competitor	1.22B	17.85	5.38	2.28%	6.55%	116.9%	5.16%	20.79
COTYCoty Inc.Product Competitor	2.25B	2.56	-5.82	-3.68%	-9.26%	-14.21%	12.32%	1.07
ELFe.l.f. Beauty, Inc.Product Competitor	3.31B	59.42	30.95	28.28%	6.84%	8.95%	3.48%	0.41
PRGOPerrigo Company plcProduct Competitor	1.6B	11.64	-1.13	-2.75%	-33.51%	-48.56%	9.06%	0.01

Compare CL vs Peers

Colgate-Palmolive Company (CL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PG

Most directly comparable listed peer for CL.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare CL against a more recognizable public peer.

Peer Set

Compare Top 5

vs PG, UL, KMB, CHD

CL Income Statement

Colgate-Palmolive Company (CL) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Sales/Revenue	15.45B	15.54B	15.69B	16.47B	17.42B	17.97B	19.46B	20.1B	20.38B
Revenue Growth %	1.7%	0.58%	0.96%	4.96%	5.77%	3.13%	8.29%	3.31%	1.4%
Cost of Goods Sold	6.13B	6.34B	6.42B	6.54B	7.13B	7.82B	8.21B	8B	8.13B
COGS % of Revenue	39.67%	40.77%	40.88%	39.69%	40.92%	43.51%	42.18%	39.77%	39.89%
Gross Profit	9.32B▲ 0%	9.21B▼ 1.3%	9.28B▲ 0.8%	9.93B▲ 7.1%	10.29B▲ 3.6%	10.15B▼ 1.4%	11.25B▲ 10.8%	12.11B▲ 7.6%	12.25B▲ 1.2%
Gross Margin %	60.33%	59.23%	59.12%	60.31%	59.08%	56.49%	57.82%	60.23%	60.11%
Gross Profit Growth %	2.09%	-1.26%	0.77%	7.07%	3.62%	-1.39%	10.85%	7.6%	1.2%
Operating Expenses	5.31B	5.36B	5.51B	6.02B	6.41B	6.57B	7.12B	7.72B	7.9B
OpEx % of Revenue	34.39%	34.46%	35.14%	36.56%	36.78%	36.54%	36.59%	38.42%	38.77%
Selling, General & Admin	5.03B	5.08B	5.23B	5.73B	6.1B	6.25B	6.78B	7.81B	7.9B
SG&A % of Revenue	32.54%	32.67%	33.35%	34.8%	35.02%	34.76%	34.83%	38.85%	38.77%
Research & Development	285M	277M	281M	290M	307M	320M	343M	355M	0
R&D % of Revenue	1.84%	1.78%	1.79%	1.76%	1.76%	1.78%	1.76%	1.77%	-
Other Operating Expenses	0	0	0	0	0	0	0	-442M	0
Operating Income	4.01B▲ 0%	3.85B▼ 4.0%	3.76B▼ 2.3%	3.91B▲ 4.0%	3.89B▼ 0.6%	3.58B▼ 7.7%	4.13B▲ 15.2%	4.38B▲ 6.1%	4.35B▼ 0.8%
Operating Margin %	25.94%	24.77%	23.97%	23.74%	22.31%	19.95%	21.23%	21.8%	21.33%
Operating Income Growth %	1.24%	-3.97%	-2.29%	3.96%	-0.64%	-7.75%	15.23%	6.1%	-0.8%
EBITDA	4.48B	4.36B	4.28B	4.45B	4.44B	4.13B	4.7B	4.99B	4.98B
EBITDA Margin %	29.02%	28.06%	27.28%	27.02%	25.5%	22.99%	24.15%	24.81%	24.42%
EBITDA Growth %	1.84%	-2.74%	-1.83%	3.95%	-0.18%	-7.02%	13.75%	6.17%	-0.2%
D&A (Non-Cash Add-back)	475M	511M	519M	539M	556M	545M	567M	605M	630M
EBIT	3.64B	3.66B	3.49B	3.81B	3.2B	2.83B	3.68B	4.25B	3.33B
Net Interest Income	-102M	-143M	-145M	-141M	-100M	-153M	-232M	-225M	-192M
Interest Income	51M	50M	47M	19M	17M	14M	55M	67M	75M
Interest Expense	153M	193M	192M	160M	117M	167M	287M	292M	267M
Other Income/Expense	-522M	-386M	-461M	-264M	-799M	-925M	-739M	-427M	-1.29B
Pretax Income	3.49B▲ 0%	3.46B▼ 0.7%	3.3B▼ 4.7%	3.65B▲ 10.5%	3.09B▼ 15.4%	2.66B▼ 13.8%	3.39B▲ 27.5%	3.96B▲ 16.6%	3.06B▼ 22.7%
Pretax Margin %	22.56%	22.29%	21.03%	22.14%	17.72%	14.8%	17.43%	19.68%	15.01%
Income Tax	1.31B	906M	774M	787M	749M	693M	937M	907M	798M
Effective Tax Rate %	37.65%	26.15%	23.45%	21.58%	24.26%	26.05%	27.62%	22.93%	26.09%
Net Income	2.02B▲ 0%	2.4B▲ 18.6%	2.37B▼ 1.4%	2.69B▲ 13.9%	2.17B▼ 19.6%	1.78B▼ 17.6%	2.3B▲ 28.9%	2.89B▲ 25.6%	2.13B▼ 26.2%
Net Margin %	13.1%	15.44%	15.08%	16.36%	12.43%	9.93%	11.82%	14.37%	10.46%
Net Income Growth %	-17.08%	18.58%	-1.38%	13.86%	-19.63%	-17.59%	28.85%	25.61%	-26.2%
Net Income (Continuing)	2.17B	2.56B	2.53B	2.86B	2.34B	1.97B	2.46B	3.05B	2.26B
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	303M	299M	441M	358M	362M	405M	348M	332M	311M
EPS (Diluted)	2.28▲ 0%	2.75▲ 20.6%	2.75▲ 0.0%	3.14▲ 14.2%	2.55▼ 18.8%	2.13▼ 16.5%	2.77▲ 30.0%	3.51▲ 26.7%	2.63▼ 25.1%
EPS Growth %	-16.18%	20.61%	0%	14.18%	-18.79%	-16.47%	30.05%	26.71%	-25.07%
EPS (Basic)	2.30	2.76	2.76	3.15	2.56	2.13	2.78	3.53	2.64
Diluted Shares Outstanding	887.8M	873M	861.1M	859.3M	848.3M	838.8M	829.2M	822.5M	811.1M
Basic Shares Outstanding	881.8M	870.6M	859.1M	856.8M	845M	836.4M	827.4M	817.7M	808.7M
Dividend Payout Ratio	75.54%	66.29%	68.19%	55.73%	77.52%	94.73%	76.04%	61.92%	85.51%

CL Balance Sheet

Colgate-Palmolive Company (CL) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Total Current Assets	4.64B	3.79B	4.18B	4.34B	4.4B	5.11B	5.28B	5.32B	5.71B
Cash & Short-Term Investments	1.53B	726M	883M	888M	832M	775M	966M	1.26B	1.29B
Cash Only	1.53B	726M	883M	888M	832M	775M	966M	1.1B	1.29B
Short-Term Investments	0	0	0	0	0	0	0	160M	0
Accounts Receivable	1.48B	1.4B	1.44B	1.26B	1.3B	1.5B	1.59B	1.52B	1.68B
Days Sales Outstanding	34.96	32.87	33.49	28.01	27.17	30.55	29.75	27.62	30
Inventory	1.22B	1.25B	1.4B	1.67B	1.69B	2.07B	1.93B	1.99B	2.03B
Days Inventory Outstanding	72.69	71.99	79.64	93.4	86.64	96.84	86.02	90.71	91.22
Other Current Assets	403M	417M	456M	513M	576M	760M	793M	553M	714M
Total Non-Current Assets	8.04B	8.37B	10.86B	11.58B	10.64B	10.62B	11.11B	10.73B	10.62B
Property, Plant & Equipment	4.07B	3.88B	3.75B	3.72B	3.73B	4.31B	4.58B	4.42B	4.66B
Fixed Asset Turnover	3.80x	4.01x	4.18x	4.43x	4.67x	4.17x	4.25x	4.55x	4.37x
Goodwill	2.22B	2.53B	3.51B	3.82B	3.28B	3.35B	3.41B	3.27B	3.12B
Intangible Assets	1.34B	1.64B	2.67B	2.89B	2.46B	1.92B	1.89B	1.76B	1.54B
Long-Term Investments	0	0	0	0	0	0	0	81M	0
Other Non-Current Assets	218M	168M	753M	857M	974M	904M	1.02B	1B	1.3B
Total Assets	12.68B▲ 0%	12.16B▼ 4.1%	15.03B▲ 23.6%	15.92B▲ 5.9%	15.04B▼ 5.5%	15.73B▲ 4.6%	16.39B▲ 4.2%	16.05B▼ 2.1%	16.33B▲ 1.8%
Asset Turnover	1.22x	1.28x	1.04x	1.03x	1.16x	1.14x	1.19x	1.25x	1.25x
Asset Growth %	4.56%	-4.06%	23.62%	5.89%	-5.53%	4.59%	4.21%	-2.12%	1.77%
Total Current Liabilities	3.41B	3.34B	4.04B	4.4B	4.05B	4B	4.74B	5.76B	5.74B
Accounts Payable	1.21B	1.22B	1.24B	1.39B	1.48B	1.55B	1.7B	1.8B	0
Days Payables Outstanding	72.15	70.37	70.37	77.77	75.73	72.42	75.53	82.4	-
Short-Term Debt	11M	12M	514M	267M	51M	25M	330M	660M	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0
Other Current Liabilities	101M	93M	70M	182M	93M	97M	122M	116M	5.74B
Current Ratio	1.36x	1.14x	1.03x	0.99x	1.09x	1.28x	1.11x	0.92x	1.00x
Quick Ratio	1.00x	0.76x	0.69x	0.61x	0.67x	0.76x	0.71x	0.58x	0.64x
Cash Conversion Cycle	35.49	34.49	42.77	43.64	38.08	54.97	40.25	35.93	-
Total Non-Current Liabilities	9.03B	8.62B	10.44B	10.41B	10.02B	10.92B	10.7B	9.74B	10.23B
Long-Term Debt	6.57B	6.35B	7.33B	7.33B	7.19B	8.74B	8.22B	7.29B	7.99B
Capital Lease Obligations	0	0	491M	476M	451M	397M	420M	456M	0
Deferred Tax Liabilities	204M	235M	507M	426M	395M	383M	361M	343M	0
Other Non-Current Liabilities	2.25B	2.03B	2.11B	2.18B	1.98B	1.4B	1.7B	1.66B	2.24B
Total Liabilities	12.43B	11.96B	14.48B	14.82B	14.07B	14.93B	15.44B	15.5B	15.96B
Total Debt	6.58B	6.37B	8.48B	8.21B	7.83B	9.27B	9.06B	8.51B	7.99B
Net Debt	5.04B	5.64B	7.6B	7.33B	7B	8.5B	8.1B	7.42B	6.7B
Debt / Equity	27.07x	32.31x	15.20x	7.46x	8.07x	11.50x	9.47x	15.65x	21.88x
Debt / EBITDA	1.47x	1.46x	1.98x	1.85x	1.76x	2.24x	1.93x	1.71x	1.60x
Net Debt / EBITDA	1.12x	1.29x	1.78x	1.65x	1.58x	2.06x	1.72x	1.49x	1.35x
Interest Coverage	23.79x	18.95x	18.19x	23.79x	27.38x	16.93x	12.82x	14.55x	12.46x
Total Equity	243M▲ 0%	197M▼ 18.9%	558M▲ 183.2%	1.1B▲ 97.3%	971M▼ 11.8%	806M▼ 17.0%	957M▲ 18.7%	544M▼ 43.2%	365M▼ 32.9%
Equity Growth %	1329.41%	-18.93%	183.25%	97.31%	-11.81%	-16.99%	18.73%	-43.16%	-32.9%
Book Value per Share	0.27	0.23	0.65	1.28	1.14	0.96	1.15	0.66	0.45
Total Shareholders' Equity	-60M	-102M	117M	743M	609M	401M	609M	212M	54M
Common Stock	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	0
Retained Earnings	20.53B	21.61B	22.5B	23.7B	24.35B	24.57B	25.29B	26.14B	0
Treasury Stock	-20.18B	-21.2B	-22.06B	-23.05B	-24.09B	-25.13B	-26.02B	-27.36B	0
Accumulated OCI	-3.85B	-4.19B	-4.27B	-4.34B	-4.39B	-4.05B	-3.94B	-4.22B	0
Minority Interest	303M	299M	441M	358M	362M	405M	348M	332M	311M

CL Cash Flow Statement

Colgate-Palmolive Company (CL) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Cash from Operations	3.05B	3.06B	3.13B	3.72B	3.33B	2.56B	3.75B	4.11B	4.2B
Operating CF Margin %	19.76%	19.66%	19.96%	22.58%	19.09%	14.23%	19.25%	20.43%	20.6%
Operating CF Growth %	-2.77%	0.07%	2.52%	18.7%	-10.59%	-23.13%	46.52%	9.67%	2.22%
Net Income	2.17B	2.56B	2.53B	2.86B	2.34B	1.97B	2.46B	3.05B	2.13B
Depreciation & Amortization	475M	511M	519M	539M	556M	545M	567M	605M	630M
Stock-Based Compensation	127M	109M	100M	107M	135M	125M	122M	135M	0
Deferred Taxes	383M	107M	17M	-120M	-132M	-78M	-98M	-77M	-109M
Other Non-Cash Items	10M	-74M	-95M	-48M	625M	723M	244M	51M	1.26B
Working Capital Changes	-115M	-155M	65M	381M	-197M	-726M	455M	344M	284M
Change in Receivables	-15M	-79M	19M	138M	-84M	-227M	-37M	-56M	-16M
Change in Inventory	-8M	-58M	-77M	-251M	-72M	-333M	194M	-100M	109M
Change in Payables	0	0	0	0	0	0	0	516M	251M
Cash from Investing	-471M	-1.17B	-2.1B	-878M	-592M	-1.6B	-742M	-534M	-817M
Capital Expenditures	-553M	-436M	-335M	-410M	-567M	-696M	-705M	-561M	-564M
CapEx % of Revenue	3.58%	2.8%	2.13%	2.49%	3.25%	3.87%	3.62%	2.79%	2.77%
Acquisitions	0	-728M	-1.71B	-452M	0	-809M	0	0	-293M
Investments	-	-	-	-	-	-	-	-	-
Other Investing	38M	7M	0	3M	-25M	52M	-33M	37M	-14M
Cash from Financing	-2.45B	-2.68B	-870M	-2.82B	-2.77B	-952M	-2.79B	-3.39B	-3.26B
Debt Issued (Net)	-29M	-179M	1.43B	-564M	-175M	1.65B	-314M	-408M	-456M
Equity Issued (Net)	-1.4B	-1.24B	-1.2B	-602M	-1.32B	-1.31B	-1.13B	-1.74B	-1.11B
Dividends Paid	-1.53B	-1.59B	-1.61B	-1.5B	-1.68B	-1.69B	-1.75B	-1.79B	-1.82B
Share Repurchases	-1.4B	-1.24B	-1.2B	-1.48B	-1.32B	-1.31B	-1.13B	-1.74B	-1.21B
Other Financing	507M	329M	513M	-152M	400M	400M	398M	547M	132M
Net Change in Cash	220M▲ 0%	-809M▼ 467.7%	157M▲ 119.4%	5M▼ 96.8%	-56M▼ 1220.0%	-57M▼ 1.8%	191M▲ 435.1%	130M▼ 31.9%	192M▲ 47.7%
Free Cash Flow	2.5B▲ 0%	2.62B▲ 4.8%	2.8B▲ 6.8%	3.31B▲ 18.3%	2.76B▼ 16.7%	1.86B▼ 32.6%	3.04B▲ 63.4%	3.55B▲ 16.6%	3.63B▲ 2.5%
FCF Margin %	16.18%	16.86%	17.83%	20.09%	15.83%	10.35%	15.62%	17.64%	17.83%
FCF Growth %	-1.84%	4.76%	6.79%	18.26%	-16.65%	-32.56%	63.44%	16.64%	2.48%
FCF per Share	2.82	3.00	3.25	3.85	3.25	2.22	3.67	4.31	4.48
FCF Conversion (FCF/Net Income)	1.51x	1.27x	1.32x	1.38x	1.54x	1.43x	1.63x	1.42x	1.97x
Interest Paid	150M	194M	185M	188M	194M	151M	280M	302M	0
Taxes Paid	1.04B	847M	803M	845M	890M	945M	937M	933M	0

CL Key Ratios

Colgate-Palmolive Company (CL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	14358.82%	1556.92%	1090.91%	627.02%	324.89%	209.07%	200.9%	260.92%	384.94%	469.09%
Return on Invested Capital (ROIC)	55.16%	57.16%	51.92%	40.32%	35.37%	35.54%	31.13%	33.76%	38.64%	43.41%
Gross Margin	60.1%	60.33%	59.23%	59.12%	60.31%	59.08%	56.49%	57.82%	60.23%	60.11%
Net Margin	16.06%	13.1%	15.44%	15.08%	16.36%	12.43%	9.93%	11.82%	14.37%	10.46%
Debt / Equity	384.29x	27.07x	32.31x	15.20x	7.46x	8.07x	11.50x	9.47x	15.65x	21.88x
Interest Coverage	26.09x	23.79x	18.95x	18.19x	23.79x	27.38x	16.93x	12.82x	14.55x	12.46x
FCF Conversion	1.29x	1.51x	1.27x	1.32x	1.38x	1.54x	1.43x	1.63x	1.42x	1.97x
Revenue Growth	-5.23%	1.7%	0.58%	0.96%	4.96%	5.77%	3.13%	8.29%	3.31%	1.4%

CL SEC Filings & Documents

Colgate-Palmolive Company (CL) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 9, 2026·SEC

Material company update

Mar 17, 2026·SEC

Material company update

Mar 12, 2026·SEC

10-K Annual Reports

FY 2026

Feb 23, 2026·SEC

FY 2025

Feb 13, 2025·SEC

FY 2024

Feb 15, 2024·SEC

10-Q Quarterly Reports

FY 2025

Oct 31, 2025·SEC

FY 2025

Aug 1, 2025·SEC

FY 2025

Apr 25, 2025·SEC

CL Frequently Asked Questions

Colgate-Palmolive Company (CL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Colgate-Palmolive Company (CL) reported $20.38B in revenue for fiscal year 2025. This represents a 133% increase from $8.75B in 1996.

Colgate-Palmolive Company (CL) grew revenue by 1.4% over the past year. Growth has been modest.

Yes, Colgate-Palmolive Company (CL) is profitable, generating $2.13B in net income for fiscal year 2025 (10.5% net margin).

Dividend & Returns

Yes, Colgate-Palmolive Company (CL) pays a dividend with a yield of 2.60%. This makes it attractive for income-focused investors.

Colgate-Palmolive Company (CL) has a return on equity (ROE) of 469.1%. This is excellent, indicating efficient use of shareholder capital.

Colgate-Palmolive Company (CL) generated $3.63B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More CL

Colgate-Palmolive Company (CL) financial analysis — history, returns, DCA and operating performance tools

Full CL Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Colgate-Palmolive Company(CL)Earnings, Financials & Key Ratios

CL Key Insights

✓Strengths

✗Weaknesses

CL Price & Volume

CL Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

CL Recent Earnings

CL Peer Comparison

Compare CL vs Peers

vs PG

vs AMZN

Compare Top 5

CL Income Statement

CL Balance Sheet

CL Cash Flow Statement

CL Key Ratios

CL SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

CL Frequently Asked Questions

Explore More CL

Full CL Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation